Bayer’s stroke drug wins fast-track review in US
The development comes as stroke remains one of the world’s biggest health threats
The development comes as stroke remains one of the world’s biggest health threats
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
Subscribe To Our Newsletter & Stay Updated